Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
3755studies shown
Showing 85-96 of 3,755
Drug study icon
RecruitingNCT07230652

Safety and Tolerability of LY03020

The registry lists this study as recruiting. Study locations are listed in China.

In Beijing
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
China
Sponsor
Luye Pharma Group Ltd.
Condition
Schizophrenia
Drug study icon
RecruitingNCT07478744

Safety study of SYT-510 in anxiety

The registry lists this study as recruiting. Study locations are listed in the United Kingdom.

In London
AnxietyDrugFrom 18 Years to 55 Years
Countries
United Kingdom
Sponsor
Synendos Therapeutics AG
Condition
Anxiety
Drug study icon
RecruitingNCT06236880

Safety study of GM-2505 in Depression

The registry lists this study as recruiting. Study locations are listed in the United Kingdom.

In Manchester
DepressionDrugFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
Gilgamesh Pharmaceuticals
Condition
Depression
Drug study icon
RecruitingNCT07592689

Study of DT120 for Major Depressive Disorder (Ascend)

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock
DepressionDrugFrom 18 Years to 74 Years
Countries
United States
Sponsor
Definium Therapeutics US, Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT06743425

A Study of a Remote ADHD Monitoring Program

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Jackson
ADHDBehavioralFrom 5 Years to 11 Years
Countries
United States
Sponsor
IDeA States Pediatric Clinical Trials Network
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.